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CLONING AND EXPRESSION OF MP13, A NEW FACTOR RELATED TO GTP REGULATION
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#Division of Neurology, University Department of Medicine, University of Hong Kong, Queen Mary Hospital,
Pokfulam Road, Hong Kong; ' Neuropharmacology Section, Laboratory of Pharmacology and Chemistry,
NIEHS/NIH, Research Triangle Park, NC 27709; ^Institute of Environmental Health Monitoring, Chinese
Academy of Preventive Medicine, Beijing 100021, P.R. China; *Department of Free Radical Biology and
Aging, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104.
Epilepsy is one of the most common forms of nervous disease. It is caused by genetic and environment factors,
such as genetic defect, damage in brain and nervousness by stress or scare. Kainic acid (KA) induces seizures
and has been widely used as an animal model for human temporal lobe epilepsy. Our preliminary study
showed that long-term induced genes in hippocampus play an important role in the regulation of recurrent
seizures induced by KA treatment. In order to identify this long-term FRA, we have constructed a cDNA
library derived from the hippocampus 6 weeks after KA treatment and screened it with an antibody raised
against the highly conserved M-peptide region of c-Fos and the other FRA. A gene, MP13, was cloned and it
contained a 1662 bp open reading frame which coded for a 554-amino-acid protein. The expressed MP13
protein was specifically recognized by the M-peptide antibody but not by c-Fos, Fos B, Fra1, and Fra2 antibodies.
Sequence analysis revealed that MP13 has a leucine zipper region, a glutamine repeat region, and has high
sequence similarity to the activator of the small GTPase Rab5. Gel retardation analysis for the translated
MP13 protein in vitro revealed that the binding of the MP13 protein to other proteins was GTP related. These
results suggested that MP13 functions as a GTP related factor.
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IN VIVO STUDY OF NEUROPEPTIDE Y IN FOCAL CEREBRAL ISCHAEMIA
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Background and Purpose: Neuropeptide Y (NPY), an endogenous peptide neurotransmitter, has been implicated
in the regulation of many physiological functions and in the pathogenesis of many human diseases. Previous
middle cerebral artery occlusion (MCAO) experiments have shown an increase in NPY within the peri-infarct
cortex. We studied the effects of exogenous NPY on infarction volume.
Methods: Adult male Sprague-Dawley rats were anaesthetised with sodium pentobarbital to undergo reversible
right-sided endovascular MCAO for 2 hours. NPY or vehicle was given via one of three ways: intracarotid
injection (10 ug/kg) at the beginning of reperfusion; intracisternal injection (10 or 30 ug/kg) at 30 minutes of
ischaemia; intra-cerebroventricular (ICV) injection (10 ug/kg) at 30 min of ischaemia. Body temperature was
maintained constant, and haemodynamic parameters were monitored during anaesthesia. Laser doppler
flowmetry (LDF) was used to record cerebral blood flow (CBF) during ischaemia and reperfusion. The rats
were decapitated on day 3, and their brains were cut into 2-mm thick coronal slices before staining with 2%
triphenyltetrazolium chloride for determination of infarction volume.
Results: The relative infarction volumes in the NPY-treated rats were 40.0±4.7% (mean± SEM; 10 rats) after
intracarotid injection, and 30.3± 5.1% (9 rats) after ICV injection, whereas the infarction volumes were smaller
in the control rats (24.0± 3.1% [7 rats] in intracarotid controls and 15.7± 3.6% [7 rats] in ICV controls; P < 0.05,
2-tailed student's t test). Following intra-cisternal injection of NPY, the relative infarction volumes were
27.8±3.4% (10 ug/kg; 11 rats) and 29.5±3.7% (30 ug/kg; 12 rats), which were not significantly different from
that of control group (21.6± 3.1%; 8 rats). A major reduction in CBF during reperfusion was observed, especially
after intra-carotid or ICV injection.
Conclusions: Exogenous NPY administered by intra-carotid or ICV injection increases the infarction volume.
Data from laser Doppler flowmetry indicates that NPY injection produces a significant reduction in CBF
during reperfusion.
- 53 -
